Cargando…
Current and Future Novel Targets of Gene Therapy for Hypertension
Traditional therapeutic approaches for the treatment and control of hypertension are effective in normalizing blood pressure (BP) in less than a third of patients with hypertension. These pharmacological approaches may have reached a plateau in their effectiveness and newer strategies need to be inv...
Autores principales: | Katovich, Michael J., Grobe, Justin L., Raizada, Mohan K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121894/ http://dx.doi.org/10.1385/1-59259-883-8:213 |
Ejemplares similares
-
ACE2, a promising therapeutic target for pulmonary hypertension
por: Shenoy, Vinayak, et al.
Publicado: (2011) -
Neuroinflammation in Pulmonary Hypertension: Concept, Facts, and Relevance
por: Hilzendeger, Aline M., et al.
Publicado: (2014) -
Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Receptor Axis: Emerging Pharmacological Target for Pulmonary Diseases
por: Shenoy, Vinayak, et al.
Publicado: (2015) -
Targeting the Vasoprotective Axis of the Renin-Angiotensin System: A Novel Strategic Approach to Pulmonary Hypertensive Therapy
por: Bradford, Chastity N., et al.
Publicado: (2010) -
The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury
por: Rathinasabapathy, Anandharajan, et al.
Publicado: (2018)